| |
| |
|
| Insider
Information: |
Cavalier David |
| Relationship: |
Director |
| City: |
Research Triangle Pk |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,000 |
|
|
Indirect Shares
|
39,748,589 |
|
|
| Direct
Value |
$4,830 |
|
|
|
Indirect Value
|
$40 |
|
|
| Total
Shares |
39,750,589 |
|
|
| Total
Value |
$4,870 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
Director, 10% Owner |
|
0 |
2011-02-16 |
39,748,589 |
Premium* |
|
|
Anixa Biosciences Inc |
ANIX |
Director |
2019-04-29 |
2,000 |
2019-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-08-18 |
4 |
B |
$0.41 |
$2,470 |
I/I |
6,000 |
10,592,152 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-10 |
4 |
A |
$0.33 |
$726 |
I/I |
2,200 |
10,594,352 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-12 |
4 |
B |
$0.36 |
$2,549 |
I/I |
7,020 |
10,601,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-15 |
4 |
A |
$0.39 |
$4,241 |
I/I |
11,000 |
10,622,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-18 |
4 |
B |
$0.39 |
$3,900 |
I/I |
10,000 |
10,622,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-22 |
4 |
A |
$0.45 |
$2,250 |
I/I |
5,000 |
10,627,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-26 |
4 |
A |
$0.40 |
$2,000 |
I/I |
5,000 |
10,632,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-09-29 |
4 |
B |
$0.43 |
$6,500 |
I/I |
15,000 |
10,647,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-10-07 |
4/A |
B |
$0.41 |
$6,200 |
I/I |
15,000 |
10,662,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-10-10 |
4/A |
B |
$0.41 |
$6,150 |
I/I |
15,000 |
10,677,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-10-10 |
4 |
A |
$0.41 |
$6,150 |
I/I |
15,000 |
10,662,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-10-14 |
4 |
B |
$0.43 |
$6,450 |
I/I |
15,000 |
10,677,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-10-14 |
4/A |
B |
$0.43 |
$6,450 |
I/I |
15,000 |
10,692,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-11-21 |
4/A |
B |
$0.33 |
$13,180 |
I/I |
40,000 |
10,732,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-11-21 |
4 |
B |
$0.33 |
$13,180 |
I/I |
40,000 |
10,717,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-11-28 |
4/A |
B |
$0.35 |
$6,950 |
I/I |
20,000 |
10,752,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-10 |
4/A |
B |
$0.35 |
$3,450 |
I/I |
10,000 |
10,762,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-16 |
4/A |
B |
$0.35 |
$690 |
I/I |
2,000 |
10,764,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-16 |
4 |
A |
$0.35 |
$690 |
I/I |
2,000 |
10,719,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-17 |
4/A |
B |
$0.39 |
$780 |
I/I |
2,000 |
10,766,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-17 |
4 |
A |
$0.39 |
$780 |
I/I |
2,000 |
10,721,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-24 |
4/A |
B |
$0.30 |
$1,470 |
I/I |
4,900 |
10,771,372 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-24 |
4 |
A |
$0.30 |
$1,470 |
I/I |
4,900 |
10,726,372 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-26 |
4 |
A |
$0.31 |
$2,440 |
I/I |
7,950 |
10,734,222 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2008-12-26 |
4/A |
B |
$0.31 |
$2,440 |
I/I |
7,950 |
10,779,222 |
2.17 |
- |
|
81 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
